Boost knowledge guided cancer therapy
Supporting the clinical decision-making process to choose the best available therapy for patients.
The clinical use of molecular modelling
Protyon creates a 3D digital model based on the genetic code of a cancer mutation. This provides detailed insights of the interaction of different drugs with the tumor, leading to predictions of the effectiveness of the available targeted therapies.
Protyon is trusted and utilized by hospitals and our partners
“Understanding how the structures of the molecules driving cancer can change will help the choice of treatments” prof. dr. Matthew Groves, CSO Protyon BV, The Netherlands
“I have had a very smooth and exciting collaboration with Protyon, so I totally recommend working with them. The interaction was easy and they were always available when I needed further discussions or analysis. Moreover, they were able to clearly explain in detail their reports, that were not easy for me to understand. Overall, I found them really professional, competent and helpful.” Arianna Marinello – Gustave Roussy, France
“We collaborated with Protyon to perform structural modeling and molecular docking analyses of a newly identified ALK resistance mutation emerging in a patient treated with lorlatinib. Their team rapidly generated structural hypotheses that helped us interpret the functional impact of the mutation and its differential sensitivity to kinase inhibitors. The quality of the modeling and the clarity of the analysis were extremely helpful for integrating structural insights into our experimental work. This collaboration illustrates how advanced computational approaches can effectively complement translational cancer research.” Luc Friboulet – Gustave Roussy, France
Knowledge based prediction of treatment outcome
Protyon provides a knowledge-based approach for the selection of medication for previously unreported mutations.
Increases life expectancy of patients
Early selection of the correct treatment approach will directly impact patient outcomes.
Lowers the burden on health care
Molecular analysis techniques are becoming more cost-effective and accessible. Our technology saves costs by eliminating ineffective treatments.
Discover how molecular modeling predicts the effectiveness of targeted therapy on mutated cancer cells
Work together with Protyon
Education for clinicians
Learn how to use molecular modeling in clinical drug treament for cancer patients.
We provide a course tailored for clinicians to help them understanding how the drivers of disease look on a molecular level and how changes to these drivers impact the selection of treatment. Protyon’s course has been medically accredited by four Dutch medical associations: NVALT, NVVP, NVRO, VKGN.
Life science
Protyon provides a computational prediction of how small molecules may interact with drug targets and mutations of these drug targets.
Molecular modeling is a powerful tool that enhances the efficiency, precision, and innovation of research and development in precision medicine.
Contact us
Feel free to reach out to us and book an appointment with one of our experts in the field of molecular modeling. We are here to support you.